Targeting the CCL2–CCR2 axis for atheroprotection

MK Georgakis, J Bernhagen, LH Heitman… - European heart …, 2022 - academic.oup.com
Decades of research have established atherosclerosis as an inflammatory disease. Only
recently though, clinical trials provided proof-of-concept evidence for the efficacy of anti …

Novel Anti-Inflammatory Therapies in Coronary Artery Disease and Acute Coronary Syndromes

Y Dimitroglou, C Aggeli, P Theofilis, P Tsioufis… - Life, 2023 - mdpi.com
Evidence suggests that inflammation plays an important role in atherosclerosis and the
consequent clinical presentation, including stable coronary artery disease (CAD) and acute …

Immunity, atherosclerosis and cardiovascular disease

J Frostegård - BMC medicine, 2013 - Springer
Atherosclerosis, the major cause of cardiovascular disease (CVD), is a chronic inflammatory
condition with immune competent cells in lesions producing mainly pro-inflammatory …

Inflammation and atherothrombosis: from population biology and bench research to clinical practice

P Libby, PM Ridker - Journal of the American College of Cardiology, 2006 - jacc.org
The concept that inflammation governs atherosclerosis and its complications has provided a
new unifying hypothesis of the links between risk factors and the cellular and molecular …

Inflammation biomarkers are associated with the incidence of cardiovascular disease: a meta-analysis

Y Liu, S Guan, H Xu, N Zhang, M Huang… - Frontiers in …, 2023 - frontiersin.org
Background Inflammation is a risk factor for cardiovascular disease (CVD), and particular
inflammatory parameters can be used to predict the incidence of CVD. The aim of this study …

Hegemony of inflammation in atherosclerosis and coronary artery disease

A Attiq, S Afzal, W Ahmad, M Kandeel - European Journal of Pharmacology, 2024 - Elsevier
Inflammation drives coronary artery disease and atherosclerosis implications. Lipoprotein
entry, retention, and oxidative modification cause endothelial damage, triggering innate and …

Targeting inflammatory pathways in cardiovascular disease: the inflammasome, interleukin-1, interleukin-6 and beyond

P Libby - Cells, 2021 - mdpi.com
Recent clinical trials have now firmly established that inflammation participates causally in
human atherosclerosis. These observations point the way toward novel treatments that add …

Targeting inflammation in coronary artery disease

RA Harrington - New England Journal of Medicine, 2017 - Mass Medical Soc
For more than 20 years, our understanding of the biology of atherosclerosis has
incorporated the so-called inflammatory hypothesis. 1, 2 Inflammatory cells and signals drive …

Inflammation, infection and atherosclerosis

PK Shah - Trends in cardiovascular medicine, 2019 - Elsevier
Atherosclerotic cardiovascular disease is a leading cause of death in much of the world.
Adoption of a healthy lifestyle and cholesterol lowering are the key measures used to …

A link between inflammation and thrombosis in atherosclerotic cardiovascular diseases: Clinical and therapeutic implications

E Oikonomou, M Leopoulou, P Theofilis… - Atherosclerosis, 2020 - Elsevier
The association between thrombosis and acute coronary syndromes is well established.
Inflammation and activation of innate and adaptive immunity are another important factor …